These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 723351)

  • 21. Isolated hepatic perfusion for liver metastases of malignant melanoma.
    Rizell M; Mattson J; Cahlin C; Hafström L; Lindner P; Olausson M
    Melanoma Res; 2008 Apr; 18(2):120-6. PubMed ID: 18337648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
    Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
    Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
    Ghussen F; Groth W; Nagel K
    Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; Nieweg OE
    J Surg Oncol; 2002 Apr; 79(4):252-5. PubMed ID: 11920783
    [No Abstract]   [Full Text] [Related]  

  • 26. Melphalan perfusion in treatment of melanoma.
    Jönsson PE
    Br J Surg; 1981 May; 68(5):369-70. PubMed ID: 7225765
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
    Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
    J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
    Schraffordt Koops H; Oldhoff J
    Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

  • 31. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
    Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
    J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
    Henneking K; Binder J; Weyers W; Schwemmle K
    Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated limb perfusion.
    Moffat EP
    Nurs Times; 1969 Jan; 65(5):138-40. PubMed ID: 5763585
    [No Abstract]   [Full Text] [Related]  

  • 34. Eleven years' experience with hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Anderson RF
    World J Surg; 1979 Jul; 3(3):305-7. PubMed ID: 473783
    [No Abstract]   [Full Text] [Related]  

  • 35. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional hyperthermic perfusion for malignant melanoma.
    Hafström LO; Ehrson H; Hugander A; Jönsson PE; Westling H
    Prog Clin Biol Res; 1982; 107():793-8. PubMed ID: 7167529
    [No Abstract]   [Full Text] [Related]  

  • 37. [Isolated hyperthermic perfusion of the extremities with cytostatic agents. A method of treatment in malignant melanoma and soft tissue sarcoma].
    Kettelhack C; Schlag P
    Dtsch Krankenpflegez; 1989 Sep; 42(9):597-601. PubMed ID: 2518209
    [No Abstract]   [Full Text] [Related]  

  • 38. Malignant melanoma and isolated limb perfusion.
    Giraud RM
    S Afr J Surg; 1984; 22(4):243-8. PubMed ID: 6523302
    [No Abstract]   [Full Text] [Related]  

  • 39. Results of hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
    Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.